Search results
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe FDA's decision was based on the randomised, double-blind, placebo-controlled T2NOW Phase III...
Can OTC monitors really change the diabetes and obesity game?
Crain s Chicago Business· 20 hours agoType 1 diabetics and some Type 2 diabetics. With nearly 100 million people with prediabetes in the U.S., some 25 million Type ...
Poop has been an easy target for microbiome research, but voyages into the small intestine shed new...
The Conversation via Yahoo News· 1 hour agoStudies have linked inflammatory changes in the small intestine microbiome to type 1 diabetes, where...
Abbott claims FDA clearances for pair of over-the-counter diabetes trackers
FierceBiotech· 4 days agoBoth are built off Abbott’s mainstay wearable CGM, the FreeStyle Libre. While the Libre Rio is...
Top doctor alarmed by weight-loss drug misuse
BBC News· 1 hour agoNHS England's medical director says he is alarmed by reports that people are using weight-loss drugs as "a quick fix" to lose a few pounds and get...
Social Media Believes This is the Real Reason Behind Oprah Winfrey's Hospitalization
The Root via Yahoo News· 2 days agoThrough X and Tik Tok, critics have accused Winfrey of using Ozempic, a type 2 diabetes medicine...
Wait—Why Am I Not Losing Weight on Ozempic?
Parade via Yahoo News· 4 days agoSpencer Nadolsky, DO, an obesity and lipid specialist and the medical director of WeightWatchers. Once-Weekly Semaglutide in Adults with Overweight or...
Gulping down GLP-1 agonists | Texarkana Gazette
Texarkana Gazette· 1 day agoIn a country where 70% of folks are overweight or obese, nearly 49 million folks have Type 2 diabetes and close to 100 million have prediabetes ...
Vivani Medical Shares Up, FDA Cleared New Drug Application to Start Diabetes Trial
Morningstar· 22 hours agoBy Sabela Ojea Shares of Vivani Medical on Thursday climbed after the company said that the Food and Drug Administration cleared its investigational new drug application, which would allow the ...
GLP-1 Discontinuation Less Common With Endocrinologists
Medscape· 4 days agoPatients taking glucagon-like peptide 1 (GLP-1) receptor agonists for obesity appear to be...